- Home
- MATH vs DTIL Comparison
MATH vs DTIL Comparison
Compare MATH & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MATH
- DTIL
- Stock Information
- Founded
- MATH 2015
- DTIL 2006
- Country
- MATH Hong Kong
- DTIL United States
- Employees
- MATH N/A
- DTIL N/A
- Industry
- MATH Finance/Investors Services
- DTIL Biotechnology: Pharmaceutical Preparations
- Sector
- MATH Finance
- DTIL Health Care
- Exchange
- MATH Nasdaq
- DTIL Nasdaq
- Market Cap
- MATH 60.8M
- DTIL 55.3M
- IPO Year
- MATH N/A
- DTIL 2019
- Fundamental
- Price
- MATH $3.28
- DTIL $5.07
- Analyst Decision
- MATH
- DTIL Strong Buy
- Analyst Count
- MATH 0
- DTIL 2
- Target Price
- MATH N/A
- DTIL $47.00
- AVG Volume (30 Days)
- MATH 142.4K
- DTIL 75.2K
- Earning Date
- MATH 10-30-2025
- DTIL 11-03-2025
- Dividend Yield
- MATH N/A
- DTIL N/A
- EPS Growth
- MATH N/A
- DTIL N/A
- EPS
- MATH 0.41
- DTIL N/A
- Revenue
- MATH $44,567,257.00
- DTIL $1,261,000.00
- Revenue This Year
- MATH N/A
- DTIL N/A
- Revenue Next Year
- MATH N/A
- DTIL $135.19
- P/E Ratio
- MATH $8.00
- DTIL N/A
- Revenue Growth
- MATH 165.86
- DTIL N/A
- 52 Week Low
- MATH $0.80
- DTIL $3.61
- 52 Week High
- MATH $4.17
- DTIL $10.71
- Technical
- Relative Strength Index (RSI)
- MATH 56.90
- DTIL 57.47
- Support Level
- MATH $3.05
- DTIL $4.89
- Resistance Level
- MATH $3.35
- DTIL $5.12
- Average True Range (ATR)
- MATH 0.21
- DTIL 0.23
- MACD
- MATH 0.07
- DTIL 0.02
- Stochastic Oscillator
- MATH 89.23
- DTIL 82.92
About MATH Metalpha Technology Holding Limited
Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and derives a majority of its revenue from Hong Kong.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.